Historical record - last NADAC publication: 1/5/2018
Product Information
EMEND TRIPACK is a brand product labeled by Merck Sharp & Dohme LLC, priced at $246.0190 per EA under NDC 00006386203. Its NADAC has been published 269 times since Nov 28, 2013.
The High Outlier badge above means this manufacturer's average price in the aprepitant market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Manufacturer
Merck Sharp & Dohme LLCNDC
00006386203
Classification
Brand
Dosage Form
KIT
Last Updated
1/5/2018
Approval Type
New Drug (NDA)
FDA Application
NDA021549On Market Since
3/26/2003
Price Statistics
The NADAC for EMEND TRIPACK has been published 269 times since Nov 28, 2013, and over the history we have for it it has risen 87.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $246.0190 per EA |
|---|---|
| All-time high | $246.0190 (Jan 16, 2019) |
| All-time low | $131.1518 (Nov 28, 2013) |
| Median price | $189.9350 |
| Average price | $193.8030 |
| Largest weekly change | +9.9% (Jan 17, 2018) |
| Weeks tracked | 269 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 61% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EMEND TRIPACK?
The current National Average Drug Acquisition Cost (NADAC) for EMEND TRIPACK, manufactured by Merck Sharp & Dohme LLC, is $246.0190 per EA (NDC 00006386203), effective Jan 16, 2019.
How has the price of EMEND TRIPACK changed over time?
Over the history we have for it, the NADAC for EMEND TRIPACK has risen 87.6%. It has been tracked across 269 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for EMEND TRIPACK?
Since Nov 28, 2013, the NADAC for EMEND TRIPACK has ranged from a low of $131.1518 (Nov 28, 2013) to a high of $246.0190 (Jan 16, 2019), with a median of $189.9350 per EA.
Are there cheaper alternatives to EMEND TRIPACK?
Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, APREPITANT 125-80-80 MG PACK, is $96.9574 per EA — about 61% below EMEND TRIPACK.
Who manufactures EMEND TRIPACK?
EMEND TRIPACK (NDC 00006386203) is labeled by Merck Sharp & Dohme LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification